Vaxart to Host Second Quarter 2025 Business Update and Financial Results Conference Call on August 13
Vaxart (OTCQX:VXRT) has scheduled its Q2 2025 business update and financial results conference call for August 13, 2025, at 4:30 p.m. ET, following the market close. The company will provide a comprehensive business update and report financial results for the quarter ended June 30, 2025.
Investors can access the conference call through a webcast or by dialing (877) 407-0832 for domestic calls or (201) 689-8433 for international calls using Conference ID 13755103. Written questions can be submitted in advance to ir@vaxart.com by August 12, 2025. A replay will be available on Vaxart's website after the event.
Vaxart (OTCQX:VXRT) ha programmato la sua conferenza per l'aggiornamento aziendale e i risultati finanziari del secondo trimestre 2025 per il 13 agosto 2025 alle 16:30 ET, dopo la chiusura del mercato. L'azienda fornirà un aggiornamento completo sull'attività e presenterà i risultati finanziari relativi al trimestre conclusosi il 30 giugno 2025.
Gli investitori potranno partecipare alla conference call tramite webcast o chiamando il numero (877) 407-0832 per chiamate nazionali oppure (201) 689-8433 per chiamate internazionali, utilizzando il codice Conference ID 13755103. Le domande scritte possono essere inviate in anticipo all'indirizzo ir@vaxart.com entro il 12 agosto 2025. Una registrazione sarà disponibile sul sito web di Vaxart dopo l'evento.
Vaxart (OTCQX:VXRT) ha programado su actualización comercial y llamada para resultados financieros del segundo trimestre de 2025 para el 13 de agosto de 2025 a las 4:30 p.m. ET, después del cierre del mercado. La compañía proporcionará una actualización completa del negocio y reportará los resultados financieros del trimestre finalizado el 30 de junio de 2025.
Los inversores pueden acceder a la llamada a través de una transmisión en vivo o llamando al (877) 407-0832 para llamadas nacionales o al (201) 689-8433 para llamadas internacionales utilizando el ID de conferencia 13755103. Las preguntas escritas pueden enviarse con anticipación a ir@vaxart.com antes del 12 de agosto de 2025. Una repetición estará disponible en el sitio web de Vaxart después del evento.
Vaxart (OTCQX:VXRT)는 2025년 8월 13일 오후 4시 30분(동부시간) 시장 마감 후 2025년 2분기 사업 업데이트 및 재무 결과 컨퍼런스 콜을 예정하고 있습니다. 회사는 2025년 6월 30일로 종료된 분기의 종합적인 사업 업데이트와 재무 결과를 보고할 예정입니다.
투자자들은 웹캐스트를 통해 또는 국내 전화 (877) 407-0832, 국제 전화 (201) 689-8433로 컨퍼런스 ID 13755103을 사용하여 컨퍼런스 콜에 참여할 수 있습니다. 사전 질문은 2025년 8월 12일까지 ir@vaxart.com으로 제출할 수 있습니다. 행사가 끝난 후 Vaxart 웹사이트에서 다시 듣기가 제공됩니다.
Vaxart (OTCQX:VXRT) a programmé sa conférence téléphonique de mise à jour commerciale et de résultats financiers du deuxième trimestre 2025 pour le 13 août 2025 à 16h30 ET, après la clôture du marché. La société fournira une mise à jour complète de ses activités et présentera les résultats financiers pour le trimestre clos au 30 juin 2025.
Les investisseurs peuvent accéder à la conférence téléphonique via un webcast ou en appelant le (877) 407-0832 pour les appels nationaux ou le (201) 689-8433 pour les appels internationaux en utilisant l’ID de conférence 13755103. Les questions écrites peuvent être envoyées à l’avance à ir@vaxart.com avant le 12 août 2025. Une rediffusion sera disponible sur le site web de Vaxart après l’événement.
Vaxart (OTCQX:VXRT) hat seine Telefonkonferenz zur Geschäftsentwicklung und den Finanzergebnissen für das zweite Quartal 2025 für den 13. August 2025 um 16:30 Uhr ET nach Börsenschluss angesetzt. Das Unternehmen wird ein umfassendes Geschäftsupdate geben und die Finanzergebnisse für das am 30. Juni 2025 endende Quartal berichten.
Investoren können über einen Webcast oder telefonisch unter (877) 407-0832 für Inlandsgespräche bzw. (201) 689-8433 für internationale Anrufe mit der Konferenz-ID 13755103 teilnehmen. Schriftliche Fragen können bis zum 12. August 2025 an ir@vaxart.com eingereicht werden. Eine Aufzeichnung wird nach der Veranstaltung auf der Webseite von Vaxart verfügbar sein.
- None.
- None.
Conference call to begin at 4:30 p.m. ET
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2025, after the market close on Wednesday, August 13, 2025. The Vaxart senior management team will host a conference call on the same day, beginning at 4:30 p.m. ET.
The conference call can be accessed using the following information:
Webcast: Click here
Date: Wednesday, August 13, 2025 – 4:30 p.m. ET
Domestic: (877) 407-0832
International: (201) 689-8433
Conference ID: 13755103
Investors may submit written questions in advance of the conference call to ir@vaxart.com by August 12, 2025.
A replay of the webcast will be available on the Company’s website at www.vaxart.com following the conclusion of the event.
About Vaxart
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Contact
Vaxart Media and Investor Relations:
Matt Steinberg
FINN Partners
IR@vaxart.com
(646) 871-8481
This press release was published by a CLEAR® Verified individual.
FAQ
When is Vaxart (VXRT) reporting Q2 2025 earnings?
How can investors join Vaxart's Q2 2025 earnings call?
Can investors submit questions for Vaxart's Q2 2025 earnings call?
Where can I find the replay of Vaxart's Q2 2025 earnings call?
